Saag MS - Search Results

1

Early virologic suppression with three-class experienced patients: 24-week effectiveness in the darunavir outcomes study.

McKinnell JA, Lin HY, Nevin CN, Willig JH, McFarland G, Genz M, Raper JL, DeLaitsch LL, Mrus JM, Klaskala W, Mugavero MJ, Saag MS. McKinnell JA, et al. Among authors: saag ms. AIDS. 2009 Jul 31;23(12):1539-46. doi: 10.1097/QAD.0b013e32832c7b5c. AIDS. 2009. PMID: 19487910

2

A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group.

Saag MS, Emini EA, Laskin OL, Douglas J, Lapidus WI, Schleif WA, Whitley RJ, Hildebrand C, Byrnes VW, Kappes JC, et al. Saag MS, et al. N Engl J Med. 1993 Oct 7;329(15):1065-72. doi: 10.1056/NEJM199310073291502. N Engl J Med. 1993. PMID: 7690462 Free article. Clinical Trial.

3

Use of virologic markers in clinical practice.

Saag MS. Saag MS. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16 Suppl 1:S3-13. doi: 10.1097/00042560-199701001-00002. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9389310 Review.

4

Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults. Abacavir Phase 2 Clinical Team.

Saag MS, Sonnerborg A, Torres RA, Lancaster D, Gazzard BG, Schooley RT, Romero C, Kelleher D, Spreen W, LaFon S. Saag MS, et al. AIDS. 1998 Nov 12;12(16):F203-9. doi: 10.1097/00002030-199816000-00002. AIDS. 1998. PMID: 9833848 Clinical Trial.

5

Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals.

Derdeyn CA, Costello C, Kilby JM, Sfakianos G, Saag MS, Kaslow R, Bucy RP. Derdeyn CA, et al. Among authors: saag ms. AIDS Res Hum Retroviruses. 1999 Aug 10;15(12):1063-71. doi: 10.1089/088922299310359. AIDS Res Hum Retroviruses. 1999. PMID: 10461826

6

Stability in the HIV vDNA pool in peripheral CD4+ T cells of untreated patients by single tube quantitative PCR.

Hockett RD Jr, Saag MS, Kilby JM, Sfakianos G, Wakefield TB, Bucy RP. Hockett RD Jr, et al. Among authors: saag ms. J Virol Methods. 2000 Jun;87(1-2):1-12. doi: 10.1016/s0166-0934(00)00139-7. J Virol Methods. 2000. PMID: 10856747

7

The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3.

Call SA, Heudebert G, Saag M, Wilcox CM. Call SA, et al. Am J Gastroenterol. 2000 Nov;95(11):3142-6. doi: 10.1111/j.1572-0241.2000.03285.x. Am J Gastroenterol. 2000. PMID: 11095332

8

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.

Call SA, Saag MS, Westfall AO, Raper JL, Pham SV, Tolson JM, Hellmann NS, Cloud GA, Johnson VA. Call SA, et al. Among authors: saag ms. J Infect Dis. 2001 Feb 1;183(3):401-8. doi: 10.1086/318078. Epub 2000 Dec 29. J Infect Dis. 2001. PMID: 11133371

9

Health-related quality of life and virologic outcomes in an HIV clinic.

Call SA, Klapow JC, Stewart KE, Westfall AO, Mallinger AP, DeMasi RA, Centor R, Saag MS. Call SA, et al. Among authors: saag ms. Qual Life Res. 2000;9(9):977-85. doi: 10.1023/a:1016668802328. Qual Life Res. 2000. PMID: 11332226

10

The impact of highly active antiretroviral therapy on HIV-specific immune function.

Saag MS. Saag MS. AIDS. 2001 Feb;15 Suppl 2:S4-10. doi: 10.1097/00002030-200102002-00002. AIDS. 2001. PMID: 11424976 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters